Senior Director Head of Market Access EUR/INT
Company
Location
London, England, United Kingdom
Posted At
4/15/2025
Advertise with us by contacting: [email protected]
Disclaimer: Hunt UK Visa Sponsors aggregates job listings from publicly available sources, such as search engines, to assist with your job hunting. We do not claim affiliation with Jazz Pharmaceuticals. For the most up-to-date job details, please visit the official website by clicking "Apply Now."
Description
If you are a current Jazz employee please apply via the Internal Career site.
Jazz Pharmaceuticals is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.
Primary Objective/ Purpose Of Position
This position is responsible for the leadership and oversight of the regional Market Access (MAX) team, alongside being a core member of the wider regional Patient Access and Value (PAV) Leadership Team and Jazz Market Access Team (JMAT), which includes all MAX team members from Jazz’s affiliates. The individual will be a seasoned and adaptable team leader with experience in rare diseases across therapeutic areas (ideally neurology and oncology), proven experience across multiple EUR/INT markets, and a strong understanding of HEOR, pricing, public policy, and product commercialisation.
The Head of MAX will lead a small team of Product Access Leads who are responsible for the overarching patient access, pricing, and reimbursement strategy for marketed Jazz products and new products from 24 months prior to planned launch (responsibility handed over from Portfolio Strategy). Product Access Leads, alongside wider cross-functional SMEs including the Regional Brand Lead and Medical Lead, generate EUR/INT plans to maximise the value of Jazz’s products. This includes optimal launch order sequence across affiliate and partner markets, supporting markets in the development and submission of their HTA dossiers, value message development and the data package to support, identification of innovative funding pathways, and maximizing the life cycle value of Jazz products including assessing the regional impact of pricing renegotiations and anticipating future market dynamics. This role is also accountable for the overarching communication of access strategy for new Jazz products – working closely with the Head of Pricing and Head of HEOR.
Alongside leadership of the MAX team and supporting the development of team members, the individual will also serve as a core member of the PAV LT. This entails ongoing, proactive engagement to deliver agreed priorities for the wider PAV and JMAT team – from optimising ways of working with affiliate MAX teams to developing professional development opportunities, departmental and enterprise budget planning, building understanding of the function across the business and leading cross-functional workstreams e.g. Joint Clinical Assessment (JCA) readiness. The Head of MAX will also regularly engage and ensure alignment with other leaders across the business – from affiliates, the region and globally – offering senior counsel, scenario planning and supporting forecasting.
Key Responsibilities
Strategic leadership
Jazz Pharmaceuticals is an equal opportunity/affirmative action employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, or any characteristic protected by law.
The successful candidate will also be eligible to participate in various benefits offerings, including, but not limited to, medical, dental and vision insurance, retirement savings plan, and flexible paid vacation. For more information on our Benefits offerings please click here: https://careers.jazzpharma.com/benefits.html.
Jazz Pharmaceuticals is a global biopharma company whose purpose is to innovate to transform the lives of patients and their families. We are dedicated to developing life-changing medicines for people with serious diseases — often with limited or no therapeutic options. We have a diverse portfolio of marketed medicines, including leading therapies for sleep disorders and epilepsy, and a growing portfolio of cancer treatments. Our patient-focused and science-driven approach powers pioneering research and development advancements across our robust pipeline of innovative therapeutics in oncology and neuroscience. Jazz is headquartered in Dublin, Ireland with research and development laboratories, manufacturing facilities and employees in multiple countries committed to serving patients worldwide. Please visit www.jazzpharmaceuticals.com for more information.
Primary Objective/ Purpose Of Position
This position is responsible for the leadership and oversight of the regional Market Access (MAX) team, alongside being a core member of the wider regional Patient Access and Value (PAV) Leadership Team and Jazz Market Access Team (JMAT), which includes all MAX team members from Jazz’s affiliates. The individual will be a seasoned and adaptable team leader with experience in rare diseases across therapeutic areas (ideally neurology and oncology), proven experience across multiple EUR/INT markets, and a strong understanding of HEOR, pricing, public policy, and product commercialisation.
The Head of MAX will lead a small team of Product Access Leads who are responsible for the overarching patient access, pricing, and reimbursement strategy for marketed Jazz products and new products from 24 months prior to planned launch (responsibility handed over from Portfolio Strategy). Product Access Leads, alongside wider cross-functional SMEs including the Regional Brand Lead and Medical Lead, generate EUR/INT plans to maximise the value of Jazz’s products. This includes optimal launch order sequence across affiliate and partner markets, supporting markets in the development and submission of their HTA dossiers, value message development and the data package to support, identification of innovative funding pathways, and maximizing the life cycle value of Jazz products including assessing the regional impact of pricing renegotiations and anticipating future market dynamics. This role is also accountable for the overarching communication of access strategy for new Jazz products – working closely with the Head of Pricing and Head of HEOR.
Alongside leadership of the MAX team and supporting the development of team members, the individual will also serve as a core member of the PAV LT. This entails ongoing, proactive engagement to deliver agreed priorities for the wider PAV and JMAT team – from optimising ways of working with affiliate MAX teams to developing professional development opportunities, departmental and enterprise budget planning, building understanding of the function across the business and leading cross-functional workstreams e.g. Joint Clinical Assessment (JCA) readiness. The Head of MAX will also regularly engage and ensure alignment with other leaders across the business – from affiliates, the region and globally – offering senior counsel, scenario planning and supporting forecasting.
Key Responsibilities
Strategic leadership
- Lead the EUR/INT Market Access team – setting strategic priorities and managing resources to optimise pricing, reimbursement, and patient access.
- Oversee new asset planning from ~24 months pre-launch, ensuring a comprehensive market access strategy that includes pricing, reimbursement and launch sequencing across the region.
- Align with Portfolio Strategy, Pricing and HEOR to develop and execute integrated market access strategies for new and existing products – ensuring alignment with business objectives and maximising the long-term value of Jazz assets throughout the lifecycle.
- Support the assessment and realisation of life cycle management opportunities for Jazz products, including scenario planning (e.g. around price renegotiations) and forecasting.
- Escalate to senior leadership notable market access opportunities and threats, and work with teams to address these issues.
- Core member of the PAV LT – entailing ongoing, proactive engagement on issues of importance to the wider PAV and JMAT team e.g. optimising ways of working, building understanding of the function across the business and leading cross-functional workstreams e.g. Joint Clinical Assessment (JCA) readiness.
- Live Jazz’s high-performance culture – adopting a growth mindset to all areas of work to elevate the ambition of the team.
- Develop and implement pricing and reimbursement strategies – working closely with affiliate access leads and national teams.
- Ensure alignment of national P&R submissions with regional strategy, adapting payer value messaging for successful HTA dossiers and negotiations.
- Identify and implement innovative market access solutions, such as Early Access programmes, alternative funding mechanisms and value-based contracting.
- Provide strategic guidance on national pricing and reimbursement pathways – ensuring evidence and value requirements are prioritised to maximise patient access and product value.
- Partner with the EUR/INT Regional Brand Teams to align market access strategy with broader commercial and medical objectives.
- Work cross-functionally with affiliates and external HTA consultants to navigate formal and informal reimbursement processes to support launch and life cycle management.
- Collaborate with Business Insights, Portfolio Strategy, HEOR and Pricing teams to inform regional financial forecasting and pricing assumptions, alongside supporting global forecasting and exploration of future indications.
- Lead cross-functional working groups of SMEs to finalise launch sequencing and reimbursement strategies.
- Engage and ensure alignment with other leaders across the business – from affiliates, the region and globally – offering senior counsel and problem solving.
- Develop and enhance the market access capabilities within Jazz by identifying and delivering training needs and best practices.
- Support affiliate market access teams with expertise and strategic guidance to ensure strong execution at the national level.
- Stay ahead of payer, health system and policy trends to proactively address market access challenges and risks.
- Evolve our processes and governance to raise market access execution excellence.
- Embed constructive challenge and real time feedback within team practices.
- Extensive experience in HTA reimbursement processes for drug launches and renegotiations in
- Experience in HEOR would be an advantage
- European markets (experience in Australia, Asia, MENA and/or LATAM).
- Proven expertise in pricing and reimbursement strategy development and execution.
- Strong leadership experience managing a drug portfolio at a regional level.
- Direct experience in market access submissions for drug launches, particularly in neurology, oncology and rare disease.
- Ability to shape early asset development and influence business development activities.
- Strong collaboration skills, with a proven ability to work cross-functionally with HEOR, pricing, medical, marketing and finance teams.
- Experience working across diverse international markets, with a deep understanding of local market dynamics and regulatory environments.
- Degree in health science, health policy or a related field required.
- MBA, PhD or Master’s degree in a related discipline preferred.
- Responsibilities may require working outside of “normal” hours to meet business demands e.g. payer authority request deadlines
- Travel will be an essential part of this role
Jazz Pharmaceuticals is an equal opportunity/affirmative action employer and all qualified applicants will receive consideration for employment without regard to race, color, religion, sex, national origin, disability status, protected veteran status, or any characteristic protected by law.
The successful candidate will also be eligible to participate in various benefits offerings, including, but not limited to, medical, dental and vision insurance, retirement savings plan, and flexible paid vacation. For more information on our Benefits offerings please click here: https://careers.jazzpharma.com/benefits.html.
Advertise with us by contacting: [email protected]
Hunt UK Visa Sponsors
Copyright © 2025